References

  1. WHO. Cardiovascular Diseases (CVDs) Fact Sheet. May 2017. Accessed April 20, 2018.
  2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 Nov;3(11):e442. doi:10.1371/journal.pmed.0030442.
  3. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. BMJ. 1989 Mar 25;298(6676):779-81.
  4. DeStefano F, Anda RF, Kahn HS, et al. Dental disease and risk of coronary heart disease and mortality. BMJ. 1993 Mar 13;306(6879):688-91.
  5. Mattila KJ, Valtonen VV, Nieminen M, et al. Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin Infect Dis. 1995 Mar;20(3):588-92.
  6. Beck JD, Eke P, Heiss G, et al. Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation. 2005 Jul 5;112(1):19-24. Epub 2005 Jun 27. doi: 10.1161/CIRCULATIONAHA.104.511998.
  7. Joshipura KJ, Rimm EB, Douglass CW, et al. Poor oral health and coronary heart disease. J Dent Res. 1996 Sep;75(9):1631-6. doi: 10.1177/00220345960750090301.
  8. Lockhart PB, Bolger AF, Papapanou PN, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012 May 22;125(20):2520-44. doi: 10.1161/CIR.0b013e31825719f3. Epub 2012 Apr 18.
  9. Mitchell ME, Sidawy AN. The pathophysiology of atherosclerosis. Semin Vasc Surg. 1998 Sep;11(3):134-41.
  10. Tonetti MS, Van Dyke TE; working group 1 of the joint EFP/AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol. 2013 Apr;84(4 Suppl):S24-9. doi: 10.1902/jop.2013.1340019.
  11. Van Dyke TE, van Winkelhoff AJ. Infection and inflammatory mechanisms. J Clin Periodontol. 2013 Apr;40 Suppl 14:S1-7. doi: 10.1111/jcpe.12088. DOI: 10.1111/jcpe.12088.
  12. Schenkein HA, Loos BG. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Clin Periodontol. 2013 Apr;40 Suppl 14:S51-69. doi: 10.1111/jcpe.12060.
  13. Janket SJ, Baird AE, Chuang SK, et al. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 May;95(5):559-69. doi: 10.1067/moe.2003.107.
  14. Mustapha IZ, Debrey S, Oladubu M, et al. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol. 2007 Dec;78(12):2289-302. doi: 10.1902/jop.2007.070140.
  15. Humphrey LL, Fu R, Buckley DI, et al. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis.J Gen Intern Med. 2008 Dec;23(12):2079-86. doi: 10.1007/s11606-008-0787-6. Epub 2008 Sep 20.
  16. Flemmig TF. Periodontitis. Ann Periodontol. 1999 Dec;4(1):32-8. doi: 10.1902/annals.1999.4.1.32.
  17. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest. 1976 Mar;34(3):235-49.
  18. Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: review of the evidence. J Clin Periodontol. 2013 Apr;40 Suppl 14:S8-19. doi: 10.1111/jcpe.12064.
  19. Nguyen CM, Kim JW, Quan VH, et al. Periodontal associations in cardiovascular diseases: The latest evidence and understanding. J Oral Biol Craniofac Res. 2015 Sep-Dec;5(3):203-6. doi: 10.1016/j.jobcr.2015.06.008. Epub 2015 Jul 29.
  20. Eke PI, Dye BA, Wei L, et al. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012 Oct;91(10):914-20. Epub 2012 Aug 30. doi: 10.1177/0022034512457373.
  21. Campese VM, Nosrati S. Diagnosis and evaluation of secondary hypertension. Clin Cornerstone. 1999;2(1):27-39.
  22. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000 Jul 29;356(9227):411-7. doi: 10.1016/S0140-6736(00)02539-3.
  23. Corvol P, Jeunemaitre X, Charru A, et al. Role of the renin-angiotensin system in blood pressure regulation and in human hypertension: new insights from molecular genetics. Recent Prog Horm Res. 1995;50:287-308.
  24. Corvol P, Jeunemaitre X, Charru A, et al. Role of the renin-angiotensin system in blood pressure regulation and in human hypertension: new insights from molecular genetics. Recent Prog Horm Res. 1995;50:287-308.
  25. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. BMJ. 1991 Apr 6;302(6780):819-24.
  26. Pan WH, Nanas S, Dyer A, et al. The role of weight in the positive association between age and blood pressure. Am J Epidemiol. 1986 Oct;124(4):612-23.
  27. Beilin LJ. Non-pharmacological management of hypertension: optimal strategies for reducing cardiovascular risk. J Hypertens Suppl. 1994 Dec;12(10):S71-81.
  28. Carvalho JJ, Baruzzi RG, Howard PF, et al. Blood pressure in four remote populations in the INTERSALT Study. Hypertension. 1989 Sep;14(3):238-46.
  29. Costa Ede A, Rose GA, Klein CH, et al. Salt and blood pressure in Rio Grande do Sul, Brazil. Bull Pan Am Health Organ. 1990;24(2):159-76.
  30. Joffres MR, Hamet P, Rabkin SW, et al. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ. 1992 Jun 1;146(11):1997-2005.
  31. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002 Feb 27;287(8):1003-10.
  32. NIH. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Hypertension. 2003;42:1206. NIH Publication 03-5233. Accessed April 20, 2018.
  33. CDC. Summary Health Statistics: National Health Interview Survey, 2014. Accessed April 20, 2018.
  34. Ram CV. Secondary hypertension: workup and correction. Hosp Pract (Off Ed). 1994 Apr 15;29(4):137-40, 143-6, 149-50.
  35. Guilbert JJ. The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon). 2003 Jul;16(2):230. doi: 10.1080/1357628031000116808.
  36. Heagerty AM, Aalkjaer C, Bund SJ, et al. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension. 1993 Apr;21(4):391-7.
  37. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72. Epub 2003 May 14. doi: 10.1001/jama.289.19.2560.
  38. Carey RM, Whelton PK2; 2017 ACC/AHA Hypertension Guideline Writing Committee. Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Ann Intern Med. 2018 Mar 6;168(5):351-358. doi: 10.7326/M17-3203. Epub 2018 Jan 23.
  39. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999 Jan 14;340(2):115-26. doi: 10.1056/NEJM199901143400207.
  40. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005 Jun 28;111(25):3481-8. doi: 10.1161/CIRCULATIONAHA.105.537878.
  41. Libby P. Inflammation in atherosclerosis. Nature. 2002 Dec 19-26;420(6917):868-74. doi: 10.1038/nature01323.
  42. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008 Jan;54(1):24-38. doi: 10.1373/clinchem.2007.097360.
  43. Barnett HJ, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med. 1995 Jan 26;332(4):238-48. doi: 10.1056/NEJM199501263320408.
  44. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 1995 Jun 8;332(23):1553-9.
  45. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 1994 May 5;330(18):1287-94. doi: 10.1056/NEJM199405053301808.
  46. Hirsh J. Oral anticoagulant drugs. N Engl J Med. 1991 Jun 27;324(26):1865-75. doi: 10.1056/NEJM199106273242606.
  47. Writing Group Members, Mozaffarian D, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. Epub 2015 Dec 16.
  48. Flemmig TF. Periodontitis. Ann Periodontol. 1999 Dec;4(1):32-8. doi: 10.1902/annals.1999.4.1.32.
  49. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest. 1976 Mar;34(3):235-49.
  50. Löe H, Anerud A, Boysen H, et al. Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol. 1986 May;13(5):431-45.
  51. Socransky SS, Haffajee AD, Goodson JM, et al. New concepts of destructive periodontal disease. J Clin Periodontol. 1984 Jan;11(1):21-32.
  52. Jeffcoat MK, Reddy MS. Progression of probing attachment loss in adult periodontitis. J Periodontol. 1991 Mar;62(3):185-9. doi: 10.1902/jop.1991.62.3.185.
  53. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999 Dec;4(1):1-6. doi: 10.1902/annals.1999.4.1.1.
  54. American Academy of Periodontology Task Force Report on the Update to the 1999 Classification of Periodontal Diseases and Conditions. J Periodontol. 2015 Jul;86(7):835-8. doi: 10.1902/jop.2015.157001. Epub 2015 May 27.
  55. Eke PI, Dye BA, Wei L, et al. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012 Oct;91(10):914-20. Epub 2012 Aug 30. doi: 10.1177/0022034512457373.
  56. Eke PI, Dye BA, Wei L, et al. Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015 May;86(5):611-22. doi: 10.1902/jop.2015.140520. Epub 2015 Feb 17.
  57. Hirschfeld L, Wasserman B. A long-term survey of tooth loss in 600 treated periodontal patients. J Periodontol. 1978 May;49(5):225-37. doi: 10.1902/jop.1978.49.5.225.
  58. McFall WT Jr. Tooth loss in 100 treated patients with periodontal disease. A long-term study. J Periodontol. 1982 Sep;53(9):539-49. doi: 10.1902/jop.1982.53.9.539.
  59. Löe H, Anerud A, Boysen H, et al. The natural history of periodontal disease in man. The rate of periodontal destruction before 40 years of age. J Periodontol. 1978 Dec;49(12):607-20. doi: 10.1902/jop.1978.49.12.607.
  60. Michalowicz BS, Aeppli DP, Kuba RK, et al. A twin study of genetic variation in proportional radiographic alveolar bone height. J Dent Res. 1991 Nov;70(11):1431-5. doi: 10.1177/00220345910700110701.
  61. Michalowicz BS, Aeppli D, Virag JG, et al. Periodontal findings in adult twins. J Periodontol. 1991 May;62(5):293-9. doi: 10.1902/jop.1991.62.5.293.
  62. Alley CS, Reinhardt RA, Maze CA, et al. HLA-D and T-lymphocyte reactivity to specific periodontal pathogens in type 1 diabetic periodontitis. J Periodontol. 1993 Oct;64(10):974-9. doi: 10.1902/jop.1993.64.10.974.
  63. Bergström J, Preber H. Tobacco use as a risk factor. J Periodontol. 1994 May;65(5 Suppl):545-50. doi: 10.1902/jop.1994.65.5s.545.
  64. Hart TC, Shapira L, Van Dyke TE. Neutrophil defects as risk factors for periodontal diseases. J Periodontol. 1994 May;65(5 Suppl):521-9. doi: 10.1902/jop.1994.65.5s.521.
  65. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 1997 Jan;24(1):72-7.
  66. Papapanou PN. Ann Periodontol. 1996 Nov;1(1):1-36. doi: 10.1902/annals.1996.1.1.1.
  67. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003 Jan 28;107(3):499-511.
  68. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:E1-40. doi: 10.1097/01.hjr.0000277984.31558.c4.
  69. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
  70. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.
  71. Gomes-Filho IS, Freitas Coelho JM, da Cruz SS, et al. Chronic periodontitis and C-reactive protein levels. J Periodontol. 2011 Jul;82(7):969-78. doi: 10.1902/jop.2010.100511. Epub 2010 Dec 28.
  72. Slade GD, Offenbacher S, Beck JD, et al. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res. 2000 Jan;79(1):49-57. doi: 10.1177/00220345000790010701.
  73. Noack B, Genco RJ, Trevisan M, et al. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol. 2001 Sep;72(9):1221-7. doi: 10.1902/jop.2000.72.9.1221.
  74. Slade GD, Ghezzi EM, Heiss G, et al. Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med. 2003 May 26;163(10):1172-9. doi: 10.1001/archinte.163.10.1172.
  75. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999 Feb 11;340(6):448-54. doi: 10.1056/NEJM199902113400607.
  76. Dye BA, Choudhary K, Shea S, et al. Serum antibodies to periodontal pathogens and markers of systemic inflammation. J Clin Periodontol. 2005 Dec;32(12):1189-99. doi: 10.1111/j.1600-051X.2005.00856.x.
  77. Pitiphat W, Savetsilp W, Wara-Aswapati N. C-reactive protein associated with periodontitis in a Thai population. J Clin Periodontol. 2008 Feb;35(2):120-5. Epub 2007 Dec 13. doi: 10.1111/j.1600-051X.2007.01179.x.
  78. Haraszthy VI, Zambon JJ, Trevisan M, et al. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000 Oct;71(10):1554-60. doi: 10.1902/jop.2000.71.10.1554.
  79. Kinane DF, Preshaw PM, Loos BG, et al. Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions--consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol. 2011 Mar;38 Suppl 11:44-8. doi: 10.1111/j.1600-051X.2010.01682.x.
  80. Teles R, Wang CY. Mechanisms involved in the association between periodontal diseases and cardiovascular disease. Oral Dis. 2011 Jul;17(5):450-61. doi: 10.1111/j.1601-0825.2010.01784.x. Epub 2011 Jan 11.
  81. Paraskevas S, Huizinga JD, Loos BG.A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008 Apr;35(4):277-90. doi: 10.1111/j.1600-051X.2007.01173.x. Epub 2008 Feb 20.
  82. Hujoel PP, White BA, García RI, et al. The dentogingival epithelial surface area revisited. J Periodontal Res. 2001 Feb;36(1):48-55.
  83. Geerts SO, Nys M, De MP, et al. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol. 2002 Jan;73(1):73-8. doi: 10.1902/jop.2002.73.1.73.
  84. Deshpande RG, Khan M, Genco CA. Invasion strategies of the oral pathogen porphyromonas gingivalis: implications for cardiovascular disease. Invasion Metastasis. 1998-1999;18(2):57-69. doi: 10.1159/000024499.
  85. Dorn BR, Dunn WA Jr, Progulske-Fox A.Invasion of human coronary artery cells by periodontal pathogens. Infect Immun. 1999 Nov;67(11):5792-8.
  86. Bokhari SA, Khan AA, Butt AK, et al.Non-surgical periodontal therapy reduces coronary heart disease risk markers: a randomized controlled trial. J Clin Periodontol. 2012 Nov;39(11):1065-74. doi: 10.1111/j.1600-051X.2012.01942.x. Epub 2012 Sep 11.
  87. Abranches J, Zeng L, Bélanger M, et al. Invasion of human coronary artery endothelial cells by Streptococcus mutans OMZ175. Oral Microbiol Immunol. 2009 Apr;24(2):141-5. doi: 10.1111/j.1399-302X.2008.00487.x.
  88. Stinson MW, Alder S, Kumar S. Invasion and killing of human endothelial cells by viridans group streptococci. Infect Immun. 2003 May;71(5):2365-72.
  89. Chou HH, Yumoto H, Davey M, et al. Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells. Infect Immun. 2005 Sep;73(9):5367-78. doi: 10.1128/IAI.73.9.5367-5378.2005.
  90. Roth GA, Moser B, Huang SJ, et al. Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. J Thromb Haemost. 2006 Oct;4(10):2256-61. doi: 10.1111/j.1538-7836.2006.02128.x.
  91. Armingohar Z, Jørgensen JJ, Kristoffersen AK, et al. Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis. J Oral Microbiol. 2014 May 15;6. doi: 10.3402/jom.v6.23408. eCollection 2014.
  92. Kholy KE, Genco RJ, Van Dyke TE, et al. Oral infections and cardiovascular disease. Trends Endocrinol Metab. 2015 Jun;26(6):315-21. doi: 10.1016/j.tem.2015.03.001. Epub 2015 Apr 16.
  93. Reyes L, Herrera D, Kozarov E, et al. Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology. J Clin Periodontol. 2013 Apr;40 Suppl 14:S30-50. doi: 10.1111/jcpe.12079.
  94. Li C, Lv Z, Shi Z, et al. Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis. Cochrane Database Syst Rev. 2014 Aug 15;(8):CD009197. doi: 10.1002/14651858.CD009197.pub2.
  95. D'Aiuto F, Nibali L, Parkar M, et al. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res. 2005 Mar;84(3):269-73. doi: 10.1177/154405910508400312.
  96. Zhou SY, Duan XQ, Hu R, et al. Effect of non-surgical periodontal therapy on serum levels of TNF-a, IL-6 and C-reactive protein in periodontitis subjects with stable coronary heart disease. Chin J Dent Res. 2013;16(2):145-51.
  97. Offenbacher S, Beck JD, Moss K, et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol. 2009 Feb;80(2):190-201. doi: 10.1902/jop.2009.080007.
  98. Bokhari SA, Khan AA, Butt AK, et al. Non-surgical periodontal therapy reduces coronary heart disease risk markers: a randomized controlled trial. J Clin Periodontol. 2012 Nov;39(11):1065-74. doi: 10.1111/j.1600-051X.2012.01942.x. Epub 2012 Sep 11.
  99. Li ZG, Li JJ, Sun CA, et al. Interleukin-18 promoter polymorphisms and plasma levels are associated with increased risk of periodontitis: a meta-analysis. Inflamm Res. 2014 Jan;63(1):45-52. doi: 10.1007/s00011-013-0669-1. Epub 2013 Oct 16.
  100. Buhlin K, Hultin M, Norderyd O, et al. Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis. Atherosclerosis. 2009 Oct;206(2):518-22. doi: 10.1016/j.atherosclerosis.2009.03.035. Epub 2009 Apr 5.
  101. Teeuw WJ, Slot DE, Susanto H, et al. Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta-analysis. J Clin Periodontol. 2014 Jan;41(1):70-9. doi: 10.1111/jcpe.12171. Epub 2013 Oct 29.
  102. Tonetti MS, D'Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med. 2007 Mar 1;356(9):911-20. doi: 10.1056/NEJMoa063186.
  103. Vidal F, Cordovil I, Figueredo CM, et al. Non-surgical periodontal treatment reduces cardiovascular risk in refractory hypertensive patients: a pilot study. J Clin Periodontol. 2013 Jul;40(7):681-7. doi: 10.1111/jcpe.12110. Epub 2013 May 3.
  104. Orlandi M, Suvan J, Petrie A, et al. Association between periodontal disease and its treatment, flow-mediated dilatation and carotid intima-media thickness: a systematic review and meta-analysis. Atherosclerosis. 2014 Sep;236(1):39-46. doi: 10.1016/j.atherosclerosis.2014.06.002. Epub 2014 Jun 17.
  105. Friedewald VE, Kornman KS, Beck JD, et al. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol. 2009 Jul;80(7):1021-32. doi: 10.1902/jop.2009.097001.
  106. Huber MA, Terézhalmy GT. Risk stratification and dental management of the patient with thyroid dysfunction. Quintessence Int. 2008 Feb;39(2):139-50.
  107. NIH. Oral health in America: a report of the Surgeon General. US Department of Health and Human Services. July 2000. Accessed April 20, 2018.
  108. Oral health: prevention is key. Lancet. 2009 Jan 3;373(9657):1. doi: 10.1016/S0140-6736(08)61933-9.
  109. Little JW, Falace DA, Miller CS, et al. Dental management of the medically compromised patient, 8th ed. St. Louis, MO. Elsevier/Mosby. 2013.
  110. CDC: Half of American adults have periodontal disease. Dent Assist. 2012 Sep-Oct;81(5):38.

Additional Resources

  • No Additional Resources Available